One product has never
scared so many pathogens.
There are more than 800 publications that describe the performance, utility and epidemiology of the BIOFIRE® Panels. Are you limiting yourself by using just one? With all six BIOFIRE panels on your side, you can detect more than 170 common pathogens and antimicrobial resistance genes with results in about an hour.
Explore our suite of panels to start giving better care, faster.
 |
 |
 |
 |
 |
 |
BIOFIRE® Joint Infection (JI) Panel
Sample: 0.2mL of synovial fluid
39 targets. 1 test. ~1 hour.
Compared to conventional methods, the BIOFIRE JI Panel may help facilitate increased diagnostic yield and improved polymicrobial detection. It targets difficult-to-grow anaerobes and fastidious pathogens which aid in pathogen guided patient management.
BIOFIRE® FILMARRAY® Pneumonia (PN) Panels
Sample: sputum (including ETA), bronchoalveolar lavage (including mini-BAL)
33 to 34 targets.* 1 test. ~1 hour.
The BIOFIRE Pneumonia Panels deliver fast, accurate pathogen identification in about one hour, which may allow physicians to put patients on appropriate therapy quicker. The BIOFIRE PN Panels’ targets include 7 antimicrobial resistance genes which may also help improve antimicrobial stewardship.
The BIOFIRE FILMARRAY Pneumonia Panel is US-FDA cleared.
The BIOFIRE FILMARRAY Pneumonia plus Panel is CE2797.
*33 targets in the BIOFIRE BIOFIRE FILMARRAY Pneumonia Panel.
34 targets in the BIOFIRE BIOFIRE FILMARRAY Pneumonia plus Panel.
BIOFIRE® FILMARRAY® Meningitis/Encephalitis (ME) Panel
Sample: 0.2mL of uncentrifuged cerebrospinal fluid (CSF)
14 targets. 1 test. ~1 hour.
Quickly distinguishing between bacterial and viral meningitis is a matter of life and death – plus it can avoid unnecessary admissions and help patients get on targeted treatment sooner.
BIOFIRE® FILMARRAY® Gastrointestinal (GI) Panel
Sample: 0.2mL of stool in Cary Blair medium
22 targets. 1 test. ~1 hour.
The BIOFIRE GI Panel tests for 22 of the most common pathogens associated with gastroenteritis and provides a streamlined stool testing workflow and fast, comprehensive results.
BIOFIRE® Blood Culture Identification 2 (BCID2) Panel
Sample Type: 0.2mL of positive blood culture
43 targets. 1 test. ~1 hour.
With gram-negative bacteria, gram-positive bacteria, yeast, and 10 antimicrobial resistance genes, the BIOFIRE BCID2 Panel can help shorten time to optimal therapy and enhance antimicrobial stewardship.
BIOFIRE® Respiratory 2.1 (RP2.1) Panels
Sample: 0.3mL of nasopharyngeal swab collected in viral transport media or saline
22 to 23 targets.* 1 test. ~45 minutes.
The BIOFIRE® Respiratory Panels have been shown to significantly reduce ICU days and duration of antibiotic use. The BIOFIRE RP2.1 Panels test for SARS-CoV-2 and other pathogens most commonly associated with respiratory infections.
The BIOFIRE Respiratory 2.1 Panel is US-FDA cleared. The BIOFIRE Respiratory 2.1 plus Panel is CE2797.
*22 targets in the BIOFIRE Respiratory 2.1 Panel. 23 targets in the BIOFIRE Respiratory 2.1 plus Panel.
BIOFIRE® Syndromic Trends
Turning test data into smart global insights.
Creating a global epidemiology network that displays BIOFIRE Panels tests results from participating laboratories and hospitals around the world. This IT Solution helps you explore site-specific epidemiological insights, keep an eye on locally circulating pathogens, and better inform your institution’s decision makers.
bioMérieux : your partner of choice on AMS
Put diagnostics at the heart of Antimicrobial Stewardship to drive informed therapy decisions. bioMériuex has the most comprehensive solutions on the market all along the patient pathway:
